INTRODUCTION
IBS, intestinal disorder
INTESTINAL DISORDER, IRRITABLE BOWEL SYNDROME
Irritable bowel syndrome (IBS) is a functional intestinal disorder that affects 5%–20% of the general population.According to the International Scientific Association for Probiotics and Prebiotics (ISAPP), probiotics are defined as “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host”.The aim of this study was to assess the effects of dietary restriction and probiotic use on IBS‐D patients. Assessment was based on positive food IgG antibody testing and cold/spicy/fried dietary restriction during a 12‐week intervention. Results of this study provide insight into a more accurate and effective approach for IBS patient treatment and management.